Guidelines for PDT in Japan.

Suppr

超能文献

作者信息

Tano Yasuo

出版信息

Ophthalmology. 2008 Mar;115(3):585-585.e6. doi: 10.1016/j.ophtha.2007.10.018.

DOI:10.1016/j.ophtha.2007.10.018

PMID:18319105

Abstract

摘要

相似文献

Guidelines for PDT in Japan.

Ophthalmology. 2008 Mar;115(3):585-585.e6. doi: 10.1016/j.ophtha.2007.10.018.

[Results of photodynamic treatment of choroidal neovascular membrane in age-related macular degeneration].

Cas Lek Cesk. 2006;145(10):800, 802-3.

Photodynamic therapy for age-related macular degeneration.

Am J Ophthalmol. 2004 Sep;138(3):513; author reply 513-4. doi: 10.1016/j.ajo.2004.05.022.

Influence of lesion size on treatment benefit with photodynamic therapy.

Clin Exp Ophthalmol. 2004 Aug;32(4):452-3. doi: 10.1111/j.1442-9071.2004.00860.x.

Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: four-year results of an open-label extension of 2 randomized clinical trials: TAP Report No. 7.

Arch Ophthalmol. 2005 Sep;123(9):1283-5. doi: 10.1001/archopht.123.9.1283.

Photodynamic therapy with verteporfin for choroidal neovascularization due to age-related macular degeneration and other causes: a New Zealand outcomes study.

Clin Exp Ophthalmol. 2007 Jan-Feb;35(1):24-31. doi: 10.1111/j.1442-9071.2007.01394.x.

Treatment of juxtafoveal choroidal neovascularization with photodynamic therapy using verteporfin in eyes with age-related macular degeneration.

Ophthalmic Surg Lasers Imaging. 2005 May-Jun;36(3):258-60.

Choroidal neovascular membranes treated with photodynamic therapy.

Arch Ophthalmol. 2003 Jun;121(6):898-903. doi: 10.1001/archopht.121.6.898.

Photodynamic therapy in adult-onset vitelliform macular dystrophy misdiagnosed as choroidal neovascularization.

Arch Ophthalmol. 2002 Dec;120(12):1761-3.

12-month retrospective study and review of photodynamic therapy with verteporfin for subfoveal choroidal neovascularization in age-related macular degeneration.

Retina. 2008 Feb;28(2):289-97. doi: 10.1097/IAE.0b013e31813ffe90.

引用本文的文献

Recurrence associated with 2-year visual acuity after subretinal tissue plasminogen activator for submacular hemorrhage in neovascular age-related macular degeneration.

Jpn J Ophthalmol. 2025 Sep 8. doi: 10.1007/s10384-025-01276-2.

The Past, Present, and Future Perspective of Photodynamic Therapy for Age-Related Macular Degeneration.

J Clin Med. 2025 Feb 13;14(4):1240. doi: 10.3390/jcm14041240.

Long-Term Prognosis of Patients with Polypoidal Choroidal Vasculopathy Treated with Photodynamic Therapy.

J Clin Med. 2023 Jul 16;12(14):4707. doi: 10.3390/jcm12144707.

Genetic Variants Affecting Anti-VEGF Drug Response in Polypoidal Choroidal Vasculopathy Patients: A Systematic Review and Meta-Analysis.

Genes (Basel). 2020 Nov 12;11(11):1335. doi: 10.3390/genes11111335.

Association between pachychoroid and long-term treatment outcomes of photodynamic therapy with intravitreal ranibizumab for polypoidal choroidal vasculopathy.

Sci Rep. 2020 May 20;10(1):8337. doi: 10.1038/s41598-020-65346-w.

Effects of blue-light irradiation during dental treatment.

Jpn Dent Sci Rev. 2018 Nov;54(4):160-168. doi: 10.1016/j.jdsr.2018.06.002. Epub 2018 Aug 31.

Efficacy and safety of ranibizumab monotherapy versus ranibizumab in combination with verteporfin photodynamic therapy in patients with polypoidal choroidal vasculopathy: 12-month outcomes in the Japanese cohort of EVEREST II study.

Clin Ophthalmol. 2018 Sep 13;12:1789-1799. doi: 10.2147/OPTH.S171015. eCollection 2018.

Three-year results of a modified photodynamic therapy procedure (Ironing PDT) for age-related macular degeneration patients with large lesions.

Clin Ophthalmol. 2016 Mar 11;10:431-6. doi: 10.2147/OPTH.S102171. eCollection 2016.

Two-year visual outcome of polypoidal choroidal vasculopathy treated with photodynamic therapy combined with intravitreal injections of ranibizumab.

Graefes Arch Clin Exp Ophthalmol. 2015 Feb;253(2):189-97. doi: 10.1007/s00417-014-2675-6. Epub 2014 May 30.

Five-year results of photodynamic therapy with and without supplementary antivascular endothelial growth factor treatment for polypoidal choroidal vasculopathy.

Graefes Arch Clin Exp Ophthalmol. 2014 Feb;252(2):227-35. doi: 10.1007/s00417-013-2433-1. Epub 2013 Aug 7.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验